New Delhi: India's health minister said on Sunday a locally-developed COVID-19 vaccine candidate could complete its final trials in a month or two, raising hopes for a rapid roll-out in a country with the world's second highest number of infections.The state-run Indian Council of Medical Research (ICMR) and privately-held Bharat Biotech this month started third-stage trials of COVAXIN, in a process that would involve 26,000 volunteers.
It is the most advanced Indian experimental vaccine."We are in the process of developing our indigenous vaccines, in the process of completing our third-phase trials in the next one or two months," Harsh Vardhan told a web conference on the pandemic.He reiterated the government's plan was to immunise 200.